Avalo stockholders elect eight directors, approve say-on-pay and auditor ratification at 2025 annual meeting

Avalo Therapeutics, Inc.

All eight director nominees elected; top vote-getter Michael Heffernan with 8,022,534 shares for.
Say-on-pay advisory resolution approved with 8,003,142 votes in favor (99.7% of votes cast).
Ratification of Ernst & Young as independent auditor for FY 2025 passed with 9,782,455 votes for.
Approximately 90% of outstanding shares (9.79M of 10.83M) were represented at the meeting.

item 5.07

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.